Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue

scientific article published on June 1994

Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID8022414

P2093author name stringE A Sausville
P M Blumberg
M G Kazanietz
P J Worland
C M Seynaeve
P433issue6
P304page(s)1207-1214
P577publication date1994-06-01
P1433published inMolecular PharmacologyQ1943386
P1476titleDifferential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue
P478volume45

Reverse relations

cites work (P2860)
Q36623957Abrogation of the radiation-induced G2 checkpoint by the staurosporine derivative UCN-01 is associated with radiosensitisation in a subset of colorectal tumour cell lines
Q37168650CHK1 inhibition as a strategy for targeting Fanconi Anemia (FA) DNA repair pathway deficient tumors
Q28250447Cell cycle kinases as therapeutic targets for cancer
Q35921522Cellular pharmacology of protein kinase Mζ (PKMζ) contrasts with its in vitro profile: implications for PKMζ as a mediator of memory
Q35867102Chk1 Activation Protects Rad9A from Degradation as Part of a Positive Feedback Loop during Checkpoint Signalling.
Q30393891Comprehensive Structural and Functional Characterization of the Human Kinome by Protein Structure Modeling and Ligand Virtual Screening
Q28609845Domain swapping used to investigate the mechanism of protein kinase B regulation by 3-phosphoinositide-dependent protein kinase 1 and Ser473 kinase
Q34670556Endothelial protein kinase C isoform identity and differential activity of PKCzeta in an athero-susceptible region of porcine aorta
Q44620620Induction by staurosporine of hepatocyte growth factor production in human skin fibroblasts independent of protein kinase inhibition
Q30306742Intracellular signals that control cell proliferation in mammalian balance epithelia: key roles for phosphatidylinositol-3 kinase, mammalian target of rapamycin, and S6 kinases in preference to calcium, protein kinase C, and mitogen-activated [...]
Q38834586Multifunctional roles of PKCδ: Opportunities for targeted therapy in human disease
Q34464422Negative regulation of mitotic promoting factor by the checkpoint kinase chk1 in simian virus 40 lytic infection
Q41175743Pediatric drug development: a perspective from the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI).
Q36614208Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01
Q38171231Protein kinase C and cancer: what we know and what we do not.
Q39098659Protein kinase C in cancer: The top five unanswered questions.
Q40815555Protein kinase C inhibition by UCN-01 induces apoptosis in human glioma cells in a time-dependent fashion
Q34457430Protein kinase C inhibitors
Q38105600Protein kinase C pharmacology: refining the toolbox
Q33969238Protein kinase C-delta regulates thrombin-induced ICAM-1 gene expression in endothelial cells via activation of p38 mitogen-activated protein kinase.
Q33982554Protein kinase Cepsilon (PKCepsilon) and Src control PKCdelta activation loop phosphorylation in cardiomyocytes
Q38168080Side-effects of protein kinase inhibitors on ion channels
Q54242951Staurosporine induces chondrogenesis of chick embryo wing bud mesenchyme in monolayer cultures through canonical and non-canonical TGF-β pathways.
Q39249805Staurosporines disrupt phosphatidylserine trafficking and mislocalize Ras proteins.
Q27024068The Novel PKCθ from Benchtop to Clinic
Q28485896Two 4N cell-cycle arrests contribute to cisplatin-resistance
Q35082212Valproic acid, an antiepileptic drug with histone deacetylase inhibitory activity, potentiates the cytotoxic effect of Apo2L/TRAIL on cultured thoracic cancer cells through mitochondria-dependent caspase activation

Search more.